Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_assertion type Assertion NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_head.
- NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_assertion description "[We summarize genetic factors that (i) impact on intervertebral disc stability, namely Collagen IX, COL9A3, COL11A1, COL11A2, COL1A1, aggrecan (AGAN), cartilage intermediate layer protein, vitamin D receptor, metalloproteinsase-3 (MMP3), MMP9, and thrombospondin-2, (ii) modify inflammation, namely interleukin-1 (IL-1) locus genes and IL-6 and (iii) and pain signalling namely guanine triphosphate (GTP) cyclohydrolase 1, catechol-O-methyltransferase, mu opioid receptor (OPMR1), melanocortin 1 receptor (MC1R), transient receptor potential channel A1 and fatty acid amide hydrolase and analgesic drug metabolism (cytochrome P450 [CYP]2D6, CYP2C9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_provenance.
- NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_assertion evidence source_evidence_literature NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_provenance.
- NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_assertion SIO_000772 19228264 NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_provenance.
- NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_assertion wasDerivedFrom befree-20150227 NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_provenance.
- NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_assertion wasGeneratedBy ECO_0000203 NP321710.RAVVT_dJIuOj8s1wZlVQYx3czDXS7rOb79SW4hOSuIbus130_provenance.